These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12145732)

  • 1. New vaccines for the prevention of tuberculosis.
    von Reyn CF; Vuola JM
    Clin Infect Dis; 2002 Aug; 35(4):465-74. PubMed ID: 12145732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Strategies for the development of new tuberculosis vaccines].
    Fattorini L
    Minerva Med; 2007 Apr; 98(2):109-19. PubMed ID: 17519853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis vaccine.
    Sarhan MA
    Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis.
    Logan KE; Chambers MA; Hewinson RG; Hogarth PJ
    Vaccine; 2005 Dec; 23(48-49):5526-32. PubMed ID: 16105710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccines: past, present and future.
    Martin C
    Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in improved tuberculosis vaccines.
    McMurray DN
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S58-62. PubMed ID: 11129910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
    Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.
    Kaufmann SH; Baumann S; Nasser Eddine A
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1068-79. PubMed ID: 17044198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
    Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM
    Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood tuberculosis: old and new vaccines.
    Hussey G; Hawkridge T; Hanekom W
    Paediatr Respir Rev; 2007 Jun; 8(2):148-54. PubMed ID: 17574159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
    Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
    FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
    Griffin JF; Mackintosh CG; Rodgers CR
    Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.